DCM
DNA icon

Dimension Capital Management’s Ginkgo Bioworks DNA Stock Holding History

Dimension Capital Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-399
Closed -$29.7K – 99
2023
Q2 		$29.7K Buy
399
+84
+27% +$4.97K 0.01% 93
2023
Q1 		$16.7K Buy
315
+1
+0.3% +$63 ﹤0.01% 104
2022
Q4 		$21.3K Buy
314
+7
+2% +$644 0.01% 104
2022
Q3 		$39K Hold
307
– – 0.01% 94
2022
Q2 		$29K Buy
307
+34
+12% +$4.15K 0.01% 102
2022
Q1 		$44K Buy
+273
New +$53.1K 0.01% 109

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Dimension Capital Management's DNA Position: Q3 2023 in Review

Dimension Capital Management sold out of Ginkgo Bioworks (DNA) in Q3 2023, closing a stake of 399 shares — an estimated $29.7K sold.

Dimension Capital Management first reported a position in DNA in Q1 2022 and held it in 6 quarters. The position peaked at $44K in Q1 2022. 348 funds tracked by Wall St. Rank hold DNA as of Q3 2023.

  • Dimension Capital Management reported no remaining Ginkgo Bioworks position as of Q3 2023 after selling out during the quarter.
  • Dimension Capital Management sold 399 Ginkgo Bioworks shares in Q3 2023, an estimated $29.7K.
  • Dimension Capital Management first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 6 quarters.
  • Dimension Capital Management's Ginkgo Bioworks position peaked at $44K in Q1 2022.
  • 348 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2023.

Based on Dimension Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.